BioNeutral Gains Initial Market Acceptance
2/25/2013 11:24:32 AM
More...
|
BioNeutral appoints Chairman of its Audit and Executive Compensation Committees
12/18/2012 6:21:00 AM
More...
|
BioNeutral Enters Into a $10 Million Equity Purchase Agreement With Southridge Partners II, Ltd.
12/14/2012 8:02:00 AM
More...
|
BioNeutral Appoints Sales Team
11/30/2012 8:26:53 AM
More...
|
BioNeutral Receives Positive Testing Results From a Global Independent Laboratory for Its Ygiene Sterilant Against Anthrax Spores
11/29/2012 9:35:36 AM
More...
|
BioNeutral Announces the Addition of Three New Members to Its Board of Directors
10/5/2012 11:26:13 AM
More...
|
BioNeutral Appoints Mr. Mark Lowenthal as Chief Executive and President
7/10/2012 8:45:08 AM
More...
|
BioNeutral Expands The Testing of Its Ygiene Sterilant Against Anthrax Spores
7/3/2012 8:38:53 AM
More...
|
BioNeutral Appoints a New Member to the Board of Directors
7/2/2012 9:22:37 AM
More...
|
BioNeutral Appoints New Board of Directors Member and Seeks to Expand Its Management Team
4/26/2012 7:57:29 AM
More...
|
|